Fiji vs Mozambique: Protecting minority investors: Ease of shareholder suits index (0-10)
Fiji
70
in 2013
Mozambique
70
in 2013
Fiji rank
44th
Mozambique rank
44th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Fiji
- Mozambique
How they compare
Fiji currently reports 70 against 70 in Mozambique, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Fiji ahead.
Fiji ranks 44th and Mozambique ranks 44th of 191 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70 | 62 | 8 | Fiji |
| 2010s | 70 | 70 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Fiji or Mozambique?
- Fiji, at 70 against 70 in Mozambique as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Fiji and Mozambique?
- 0, with Fiji ahead.
- How many years of comparable data are there for Fiji and Mozambique?
- 9 years are reported by both, from 2005 to 2013.
- How do Fiji and Mozambique rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Fiji ranks 44th and Mozambique ranks 44th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.